Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
About this item
Full title
Author / Creator
Wolff, Daniel , Cutler, Corey , Lee, Stephanie J. , Pusic, Iskra , Bittencourt, Henrique , White, Jennifer , Hamadani, Mehdi , Arai, Sally , Salhotra, Amandeep , Perez-Simon, Jose A. , Alousi, Amin , Choe, Hannah , Kwon, Mi , Bermúdez, Arancha , Kim, Inho , Socié, Gerard , Chhabra, Saurabh , Radojcic, Vedran , O’Toole, Timothy , Tian, Chuan , Ordentlich, Peter , DeFilipp, Zachariah , Kitko, Carrie L. and AGAVE-201 Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
A study in patients with chronic GVHD evaluated three doses of axatilimab, a colony-stimulating factor 1 receptor antibody. The lowest dose appeared to maximize response with the fewest adverse effects.
Alternative Titles
Full title
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
Authors, Artists and Contributors
Author / Creator
Cutler, Corey
Lee, Stephanie J.
Pusic, Iskra
Bittencourt, Henrique
White, Jennifer
Hamadani, Mehdi
Arai, Sally
Salhotra, Amandeep
Perez-Simon, Jose A.
Alousi, Amin
Choe, Hannah
Kwon, Mi
Bermúdez, Arancha
Kim, Inho
Socié, Gerard
Chhabra, Saurabh
Radojcic, Vedran
O’Toole, Timothy
Tian, Chuan
Ordentlich, Peter
DeFilipp, Zachariah
Kitko, Carrie L.
AGAVE-201 Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3106733096
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3106733096
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2401537
